Frequency Therapeutics Stock Today
| KRRO Stock | 23.76 1.86 8.49% |
PerformanceVery Weak
| Odds Of DistressAverage
|
Frequency Therapeutics is selling at 23.76 as of the 22nd of March 2025; that is 8.49 percent increase since the beginning of the trading day. The stock's open price was 21.9. Frequency Therapeutics has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 6th of November 2023 | Category Healthcare | Classification Health Care |
Frequency Therapeutics is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 9.37 M outstanding shares of which 813.63 K shares are now shorted by private and institutional investors with about 13.05 trading days to cover. More on Frequency Therapeutics
Moving together with Frequency Stock
Moving against Frequency Stock
Frequency Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President, CEO | Ram MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Frequency Therapeutics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Frequency Therapeutics' financial leverage. It provides some insight into what part of Frequency Therapeutics' total assets is financed by creditors.
| |||||
Frequency Therapeutics (KRRO) is traded on NASDAQ Exchange in USA. It is located in One Kendall Square, Cambridge, MA, United States, 02139 and employs 104 people. Frequency Therapeutics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 205.62 M. Frequency Therapeutics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 9.37 M outstanding shares of which 813.63 K shares are now shorted by private and institutional investors with about 13.05 trading days to cover.
Frequency Therapeutics generates negative cash flow from operations
Check Frequency Therapeutics Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Frequency Therapeutics is USD205.62 Million. The majority of Frequency Therapeutics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Frequency Therapeutics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Frequency Therapeutics. Please pay attention to any change in the institutional holdings of Frequency Therapeutics as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Frequency Ownership Details
Frequency Therapeutics Historical Income Statement
Frequency Stock Against Markets
Frequency Therapeutics Corporate Management
| Shelby JD | Senior Counsel | Profile | |
| Vineet MBA | Chief Officer | Profile | |
| Ravi Ramadas | Vice Development | Profile | |
| Oliver Dolan | Interim Officer | Profile | |
| Steven Colletti | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Frequency Therapeutics. If investors know Frequency will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Frequency Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Frequency Therapeutics is measured differently than its book value, which is the value of Frequency that is recorded on the company's balance sheet. Investors also form their own opinion of Frequency Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Frequency Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Frequency Therapeutics' market value can be influenced by many factors that don't directly affect Frequency Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Frequency Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Frequency Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Frequency Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.